ES557628A0 - Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores - Google Patents

Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores

Info

Publication number
ES557628A0
ES557628A0 ES557628A ES557628A ES557628A0 ES 557628 A0 ES557628 A0 ES 557628A0 ES 557628 A ES557628 A ES 557628A ES 557628 A ES557628 A ES 557628A ES 557628 A0 ES557628 A0 ES 557628A0
Authority
ES
Spain
Prior art keywords
hypertensive
procedure
preparation
dihydropyridine derivatives
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557628A
Other languages
English (en)
Other versions
ES8802449A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/700,439 external-priority patent/US4595690A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES8802449A1 publication Critical patent/ES8802449A1/es
Publication of ES557628A0 publication Critical patent/ES557628A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20Free hydroxyl or mercaptan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES557628A 1985-02-11 1987-07-16 Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores Expired ES8802449A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/700,439 US4595690A (en) 1985-02-11 1985-02-11 Antihypertensive dihydropyridine derivatives
US06/808,401 US4672071A (en) 1985-02-11 1985-12-12 Antihypertensive dihydropyridine compositions, optical isomers and intermediates

Publications (2)

Publication Number Publication Date
ES8802449A1 ES8802449A1 (es) 1988-07-01
ES557628A0 true ES557628A0 (es) 1988-07-01

Family

ID=27106619

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551809A Expired ES8708130A1 (es) 1985-02-11 1986-02-10 Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores
ES557628A Expired ES8802449A1 (es) 1985-02-11 1987-07-16 Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551809A Expired ES8708130A1 (es) 1985-02-11 1986-02-10 Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores

Country Status (15)

Country Link
US (1) US4672071A (es)
EP (1) EP0191448A3 (es)
JP (1) JPS61210071A (es)
KR (1) KR860006442A (es)
AU (1) AU591093B2 (es)
DK (1) DK64286A (es)
ES (2) ES8708130A1 (es)
FI (1) FI860584A (es)
GR (1) GR860384B (es)
HU (2) HU198019B (es)
IL (1) IL77843A (es)
NO (1) NO860458L (es)
PH (1) PH22806A (es)
PL (1) PL257890A1 (es)
PT (1) PT81987B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2576843A (en) * 1944-12-30 1951-11-27 Rosenblads Patenter Ab Heat exchange apparatus
US2788065A (en) * 1950-08-14 1957-04-09 Rosenblads Patenter Ab Surface type evaporator employing channel switching for cleaning purposes
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
US4886819A (en) * 1986-08-27 1989-12-12 The Green Cross Corporation Dihydropyridine derivatives and pharmaceutical composition thereof
JPH0686429B2 (ja) * 1986-08-27 1994-11-02 株式会社ミドリ十字 ジヒドロピリジン誘導体
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
US5576439A (en) * 1994-10-28 1996-11-19 Ciba-Geigy Corporation Dihydropyridinecarboxylic acid anhydrides
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
CH583702A5 (en) * 1973-02-13 1977-01-14 Science Union & Cie Anti-hypertensive dihydropyridines - 4-aryl 2,5-dihydropyridine 3,5-dicarboxylic esters
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2639498A1 (de) * 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8503426D0 (en) * 1985-02-11 1985-03-13 Ici Plc Pyridine derivatives
US4595690A (en) * 1985-02-11 1986-06-17 Syntex (U.S.A.) Inc. Antihypertensive dihydropyridine derivatives

Also Published As

Publication number Publication date
HUT41732A (en) 1987-05-28
FI860584A0 (fi) 1986-02-10
ES8802449A1 (es) 1988-07-01
ES551809A0 (es) 1987-10-16
NO860458L (no) 1986-08-12
AU5336386A (en) 1986-08-14
KR860006442A (ko) 1986-09-11
PH22806A (en) 1988-12-27
EP0191448A2 (en) 1986-08-20
HUT44501A (en) 1988-03-28
ES8708130A1 (es) 1987-10-16
JPS61210071A (ja) 1986-09-18
HU198478B (en) 1989-10-30
US4672071A (en) 1987-06-09
AU591093B2 (en) 1989-11-30
PL257890A1 (en) 1988-07-21
EP0191448A3 (en) 1987-08-19
HU198019B (en) 1989-07-28
PT81987A (en) 1986-03-01
IL77843A (en) 1989-07-31
DK64286D0 (da) 1986-02-10
PT81987B (en) 1987-08-13
GR860384B (en) 1986-05-09
FI860584A (fi) 1986-08-12
DK64286A (da) 1986-08-12

Similar Documents

Publication Publication Date Title
ES557231A0 (es) Procedimiento para la preparacion de 3-ariluracilos
ES551625A0 (es) Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
MX163569B (es) Procedimiento para la preparacion de benzoil-ureas
ES551069A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbenicina
IT1196488B (it) Poli-4-aminopirrol-2-carbossamido derivati e procedimento per la loro preparazione
ES556514A0 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
MX162552A (es) Procedimiento para la preparacion de benzoil-ureas
ES551809A0 (es) Procedimiento para la preparacion de derivados de dihidropiridina antihipertensores
ES548651A0 (es) Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
IT1214726B (it) Derivati di glucosilmoranolina eprocedimento per la loro preparazione
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES557423A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
MX162939B (es) Procedimiento mejorado para la preparacion de monoterbutiltolueno-diamina
ES555278A0 (es) Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES555158A0 (es) Procedimiento para la preparacion de terpolimeros de etilenopropileno-dieno
ES557233A0 (es) Procedimiento para la preparacion de 3-ariluracilos
ES551777A0 (es) Procedimiento de preparacion de derivados de 3-hidroxi-3-fenilpiperidina
ES551817A0 (es) Un procedimiento para la preparacion de derivados de dihidropiridina
MX7433E (es) Procedimiento para la preparacion de derivados de s-triazinas
ES550600A0 (es) Procedimiento para la preparacion de derivados de benzodia- zepina
ES541885A0 (es) Procedimiento para la preparacion de derivados de 3-hidroxi-5-mercapto-2-hetexicarboniltiofenos
ES549163A0 (es) Procedimiento para la preparacion de la 1-cinamil-4- benzi- drilpiperazina
ES549380A0 (es) Procedimiento para la preparacion de derivados de piperacina